{"id":"W4379645897","doi":"10.1200/jco.2023.41.17_suppl.lba8505","title":"IND227 phase III (P3) study of cisplatin/pemetrexed (CP) with or without pembrolizumab (pembro) in patients (pts) with malignant pleural mesothelioma (PM): A CCTG, NCIN, and IFCT trial.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Surrey Memorial Hospital; University of Ottawa; CancerCare Manitoba; Ottawa Hospital; Princess Margaret Cancer Centre; Queen's University; University Health Network; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pemetrexed; Carboplatin; Pembrolizumab; Internal medicine; Lung cancer; Oncology; Tolerability; Progression-free survival; Neutropenia; Cancer; Chemotherapy; Cisplatin; Adverse effect; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001359712,0.0002429692,0.001888541,0.0004023976,0.00004843383,0.000009099875,0.0001453301,0.000178715,0.0001134595],"category_scores_gemma":[0.0007222005,0.0001299615,0.0001562777,0.0005198757,0.0002702176,0.0001620257,0.00008149643,0.0005006682,0.000007184974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001242389,"about_ca_system_score_gemma":0.0006829664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008680842,"about_ca_topic_score_gemma":0.0003131826,"domain_scores_codex":[0.9958034,0.0004351615,0.002293806,0.0003185874,0.0008628031,0.0002862353],"domain_scores_gemma":[0.99637,0.001169946,0.001675588,0.0002156064,0.000156544,0.0004122788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4215111,0.0146134,0.5536306,0.00003417253,0.0003239059,0.0006241899,0.0002337781,0.00001870556,0.00003051951,0.000002140484,0.0002036838,0.008773814],"study_design_scores_gemma":[0.3092597,0.1373684,0.5514848,0.000164852,0.0004861818,0.00006355503,0.0007536231,0.0001182098,0.00001358795,0.00001312794,0.0001753639,0.00009868802],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981642,0.00004783413,0.000005377364,0.0002792605,0.0001881381,0.001092877,0.00001934588,0.000012559,0.0001904264],"genre_scores_gemma":[0.9987761,0.00008413261,0.0003840065,0.0002555454,0.0002039575,0.00002383277,0.00001619033,0.00003153419,0.0002246801],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.122755,"threshold_uncertainty_score":0.5299674,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.105704442441887,"score_gpt":0.4540090366309261,"score_spread":0.348304594189039,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}